Your browser doesn't support javascript.
loading
The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India.
Ananthakrishnan, Ramya; Thiagesan, Rajeswaran; Auguesteen, Sheela; Karunakaran, Nalini; Jayabal, Lavanya; M, Jagadeesan; Stevens, Robert; Codlin, Andrew; Creswell, Jacob.
  • Ananthakrishnan R; REACH - Resource Group for Education and Advocacy for Community Health, Chennai, Tamil Nadu, India.
  • Thiagesan R; REACH - Resource Group for Education and Advocacy for Community Health, Chennai, Tamil Nadu, India.
  • Auguesteen S; REACH - Resource Group for Education and Advocacy for Community Health, Chennai, Tamil Nadu, India.
  • Karunakaran N; REACH - Resource Group for Education and Advocacy for Community Health, Chennai, Tamil Nadu, India.
  • Jayabal L; GCC RNTCP - Greater Chennai Corporation Revised National Tuberculosis Control Programme Chennai, Tamil Nadu, India.
  • M J; GCC RNTCP - Greater Chennai Corporation Revised National Tuberculosis Control Programme Chennai, Tamil Nadu, India.
  • Stevens R; Independent Consultant, Manchester, United Kingdom.
  • Codlin A; Stop TB Partnership, TB REACH, Geneva, Switzerland.
  • Creswell J; Stop TB Partnership, TB REACH, Geneva, Switzerland.
PLoS One ; 15(11): e0241203, 2020.
Article en En | MEDLINE | ID: mdl-33147240
ABSTRACT
Tuberculosis prevalence surveys have demonstrated the benefit of screening with chest x-ray (CXR) and sensitive diagnostic tests compared to symptoms and smear microscopy. However, in programmatic practice there is little evidence on the yield of different algorithms. We implemented contact tracing in Chennai, India for adult sputum-positive TB patients registered from January 2015 to March 2016. Patients with symptoms or abnormal X-ray findings further underwent testing using Xpert MTB/RIF (Xpert) and smear microscopy. A retrospective cohort study was done to summarize the key findings. We verbally screened 5553 contacts for symptoms, CXR through private sector collaboration, Xpert, and smear microscopy. Overall, 1312 (23.6%) contacts screened positive. CXR alone identified 531 (40.5%) of them, 679 (51.8%) were symptom-positive only, while 102 (7.8%) were positive on both the symptom and CXR screen. Overall, 35 bacteriologically positive cases were identified (0.7%). A standard approach of symptoms screening followed by microscopy identified only 9 (25.7%) of the total number of bacteriologically positive cases, whereas the combination of a CRX screening followed by microscopy identified 13 (37.1%) of the cases. The algorithm of symptoms screening followed by Xpert testing, detected 20 cases, whereas the combination of symptoms and CXR followed by Xpert increased this number to 35 (75% increase compared to symptoms and Xpert). Optimal use of more sensitive screening tests, better diagnostic tests, and novel private sector engagement can improve diagnostic yield in a programmatic setting.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esputo / Tuberculosis Pulmonar / Tamizaje Masivo / Trazado de Contacto / Mycobacterium tuberculosis Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esputo / Tuberculosis Pulmonar / Tamizaje Masivo / Trazado de Contacto / Mycobacterium tuberculosis Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2020 Tipo del documento: Article